The intellectual capacity of patients with Laron syndrome (LS) differs with various molecular defects of the growth hormone receptor gene. Correlation with CNS abnormalities

Hormone and Metabolic Research

Volumn 37, Issue 12, 2005, Pages 757-760

  Shevah, O ^a   Kornreich, L ^a   Galatzer, A ^a   Laron, Zvi ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Brain abnormalities; Brain MRI; IGF I deficiency; Intelligence quotient; Laron syndrome; Primary growth hormone insensitivity

Indexed keywords

GROWTH HORMONE RECEPTOR;

ADULT; ARTICLE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EXON; FEMALE; GENE MUTATION; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; LARON SYNDROME; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; PSYCHOSOCIAL DEVELOPMENT; REPORTER GENE;

ADULT; BRAIN; FEMALE; GENE DELETION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTELLIGENCE; LARON SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POINT MUTATION; RECEPTORS, SOMATOTROPIN;

EID: 29744468658     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-921097     Document Type: Article

References (38)

1. Laron Z, Pertzelan A, Karp M. Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sci 1968; 4: 883-894
2. Eshet R, Laron Z, Pertzelan A, Dintzman M. Defect of human growth hormone receptors in the liver of two patients with Laron type dwarfism. Isr J Med Sci 1984; 20: 8-11
3. Godowski PJ, Leung DW, Meacham L, Galgagni JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron type dwarfism. Proc Natl Acad Sci USA 1989; 86: 8083-8088
4. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay MC, Goosens M. Laron dwarfism and mutations of the growth hormone receptor gene. N Engl J Med 1989; 321: 989-995
5. Laron Z, Klinger B, Eshet R, Kaneti H, Karasik A, Silbergeld A. Laron syndrome due to a post-receptor defect: response to IGF-I treatment. Isr J Med Sci 1993; 29: 757-763
6. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ, Rosenfeld RG. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 2003; 349: 1139-1147
7. Laron Z, Pertzelan A, Karp M, Kowaldo-Silbergeld A, Daughaday WH. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 1971; 33: 332-342
8. Laron Z. Natural history of the classical form of primary growth hormone (GH) resistance (Laron Syndrome). J Pediatr Endocrinol Metab 1999; 12: 231-249
9. Laron Z. Laron Syndrome (primary GH resistance or insensitivity). The personal experience 1958-2003. J Clin Endocrinol Metab 2004; 89: 1031-1044
10. Laron Z. Laron Type Dwarfism (Hereditary Somatomedin Deficiency): A Review. In: Frick P, Von Harnack GA, Kochsiek K, Martini GA, Prader A (eds). Advances in Internal Medicine and Pediatrics. Berlin-Heidelberg: Springer-Verlag, 1984: 117-150
11. Laron Z. Final height and psychosocial outcome of patients with Laron syndrome (primary GH resistance): a model of genetic IGF-I deficiency. Chapter 23. In: Gilli G, Schell L, Benso L (eds). Human Growth from Conception to Maturity. London: Smith-Gordon Publ., 2002: 215-225
12. Kornreich L, Horev G, Schwarz M, Karmazyn B, Laron Z. Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity). Eur J Endocrinol 2002; 146: 499-503
13. Shevah O, Rubinstein M, Laron Z. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. Isr Med Assoc J 2004; 6: 630-633
14. Wechsler D. The Wechsler intelligence scale for children - revised. New York Psychological Corporation, 1974
15. Wechsler D. The Wechsler adult intelligence scale - revised. New York Psychological Corporation, 1981
16. Terman LM, Merrill MA. Revised Stanford-Binet Scales (in Hebrew). Boston: Houghton-Miffin Co, 1965
17. Anlar B, Sullivan KA, Feldman EL. Insulin-like growth factor-I and central nervous system development. Horm Metab Res 1999; 31: 120-125
18. Laron Z. Growth Hormone and Insulin-Like Growth Factor-I: Effects on the Brain. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT (eds). Hormones, Brain and Behavior ch 85. San Diego-Amsterdam: Academic Press (Elsevier Science), 2002: 75-96
19. Coculescu M. Blood-brain barrier for human growth hormone and insulin-like growth factor. J Pediatr Endocrinol Metab 1999; 12: 113-124
20. Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1999; 135: 1753-1761
21. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system - localization and functional significance. Horm Res 1996; 45: 18-22
22. Meyer-Bahlburg HFL, Feinman JA, MacGillivray MH, Aceto T. Growth hormone deficiency, brain development, and intelligence. Am J Dis Child 1978; 132: 565-572
23. Laron Z, Galatzer A. Growth hormone, somatomedin and prolactin - relationship to brain function. Brain Develop 1985; 7: 559-567
24. Brown K, Rodgers J, Johnstone H, Adams W, Clarke M, Gibson M, Cheetham T. Abnormal cognitive function in treated congenital hypopituitarism. Arch Dis Child 2004; 89: 827-830
25. Laron Z, Galatzer A. Effect of hGH on head circumference and IQ in isolated growth hormone deficiency. Early Hum Develop 1981; 5: 211-214
26. Almqvist O, Thoren M, Saaf M, Eriksson O. Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study. Psychoneuroendocrinology 1986; 11: 347- 352
27. Deijen JB, de Boer H, Blok GJ, van der Veen EA. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996; 21: 313-322
28. Frankel JJ, Laron Z. Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone. Isr J Med Sci 1968; 4: 953-961
29. Galatzer A, Aran O, Nagelberg N, Rubitzek J, Laron Z. Cognitive and psychosocial functioning of young adults with Laron syndrome. Pediatr Adolesc Endocrinol 1993; 24: 53-60
30. Woods KA, Dastot F, Preece MA, Clark AJL, Postel-Vinay M-C, Chatelain PC, Ranke MB, Rosenfeld RG, Amselem S, Savage MO. Phenotype: Genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997; 82: 3529-3535
31. Kranzler JH, Rosenbloom AL, Martinez V, Aguirre J. Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: A controlled study in genetically homogeneous population. J Clin Endocrinol Metab 1998; 83: 1953-1958
32. Murakami Y, Yamashita Y, Matsuishi T, Utsunomiya H, Okudera T, Hashimoto T. Cranial MRI of neurologically impaired children suffering from neonatal hypoglycaemia. Pediatr Radiol 1999; 29: 23-27
33. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-1367
34. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, Kiess W, Klammt J, Kratzch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ, Chernausek SD. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349: 2211-2222
35. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor 1 levels and increased life span. Endocrinology 2003; 144: 3799-3810
36. Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM. Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci 2004; 19: 2069-2079
37. Turnley AM, Faux CH, Rietze RL, Coonan JR, Bartlett PF. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nature Neurosci 2002; 5: 1155-1162
38. Galli-Tsinopoulos A, Nousia-Arvanitakis S, Tsinopoulos I, Bechlivanides C, Shevah O, Laron Z. Laron syndrome. First report from Greece. Hormones 2003; 2: 120-124